| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | RSS | TABLE OF CONTENTS |
|
|
|
||||||||
|
||||||||||
Clinical Investigations |
Department of Cardiology and PET Center, Institute for Cardiovascular Research-VU, VU Medical Center, Amsterdam, The Netherlands
Image-derived input functions (IDIF) are frequently used in cardiac 18F-FDG PET studies for determination of the myocardial metabolic rate of glucose (MRGlu). The purpose of this study was to assess which vascular structure is most suited for defining the IDIF, using online arterial blood sampling (AS) as the gold standard. Methods: In 18 patients with ischemic heart disease, 370 MBq FDG were injected during a hyperinsulinemic euglycemic clamp. Studies were performed with a Siemens/CTI HR+ PET scanner using a dynamic scanning protocol. A fully automated blood-sampling device was used for continuous AS. IDIF were obtained using regions of interest (ROIs) of 3 different sizes defined on the left ventricle (LV), left atrium (LA), ascending aorta (AA), and descending aorta (DA). MRGlu was calculated with all input functions. Ratios between MRGlu obtained with IDIF and AS were calculated for each patient. Results: Time–activity curves from smaller ROIs suffered more from statistical noise with only a modest reduction of spillover effects, which led to more variation in calculated MRGlu. Mean ratios of MRGlu obtained with IDIF and AS were close to 1 when AA and DA (0.97 ± 0.07 and 1.00 ± 0.11, respectively) were used to define the input function. However, when LA and LV were used, mean ratios were 0.81 ± 0.06 and 0.79 ± 0.08, respectively, reflecting a significant underestimation of MRGlu. The use of AA for defining the input function resulted in the best agreement with AS and the smallest interobserver variation. Conclusion: The ascending aorta is the structure of choice for defining IDIF and a large ROI (diameter, approximately 15 mm) should be used to minimize the effects of statistical noise.
Key Words: PET • input function • FDG • myocardial metabolic rate of glucose
This article has been cited by other articles:
|
|
 |
|
  D. Vriens, L.-F. de Geus-Oei, W. J.G. Oyen, and E. P. Visser A Curve-Fitting Approach to Estimate the Arterial Plasma Input Function for the Assessment of Glucose Metabolic Rate and Response to Treatment J. Nucl. Med., December 1, 2009; 50(12): 1933 - 1939. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Zanotti-Fregonara, R. Maroy, C. Comtat, S. Jan, V. Gaura, A. Bar-Hen, M.-J. Ribeiro, and R. Trebossen Comparison of 3 Methods of Automated Internal Carotid Segmentation in Human Brain PET Studies: Application to the Estimation of Arterial Input Function J. Nucl. Med., March 1, 2009; 50(3): 461 - 467. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. J. de Langen, M. Lubberink, R. Boellaard, M. D. Spreeuwenberg, E. F. Smit, O. S. Hoekstra, and A. A. Lammertsma Reproducibility of Tumor Perfusion Measurements Using 15O-Labeled Water and PET J. Nucl. Med., November 1, 2008; 49(11): 1763 - 1768. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Tomasi, P. Edison, A. Bertoldo, F. Roncaroli, P. Singh, A. Gerhard, C. Cobelli, D. J. Brooks, and F. E. Turkheimer Novel Reference Region Model Reveals Increased Microglial and Reduced Vascular Binding of 11C-(R)-PK11195 in Patients with Alzheimer's Disease J. Nucl. Med., August 1, 2008; 49(8): 1249 - 1256. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y.-H. D. Fang and R. F. Muzic Jr. Spillover and Partial-Volume Correction for Image-Derived Input Functions for Small-Animal 18F-FDG PET Studies J. Nucl. Med., April 1, 2008; 49(4): 606 - 614. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Schroeder, M. F. Vidal Melo, G. Musch, R. S. Harris, J. G. Venegas, and T. Winkler Image-Derived Input Function for Assessment of 18F-FDG Uptake by the Inflamed Lung J. Nucl. Med., November 1, 2007; 48(11): 1889 - 1896. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B.-K. Teo, Y. Seo, S. L. Bacharach, J. A. Carrasquillo, S. K. Libutti, H. Shukla, B. H. Hasegawa, R. A. Hawkins, and B. L. Franc Partial-Volume Correction in PET: Validation of an Iterative Postreconstruction Method with Phantom and Patient Data J. Nucl. Med., May 1, 2007; 48(5): 802 - 810. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. M. Sondergaard, M. Bottcher, M. Marie Madsen, O. Schmitz, S. B. Hansen, T. T. Nielsen, and H. E. Botker Impact of Type 2 Diabetes on Myocardial Insulin Sensitivity to Glucose Uptake and Perfusion in Patients with Coronary Artery Disease J. Clin. Endocrinol. Metab., December 1, 2006; 91(12): 4854 - 4861. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L.-F. de Geus-Oei, E. P. Visser, P. F.M. Krabbe, B. A. van Hoorn, E. B. Koenders, A. T. Willemsen, J. Pruim, F. H.M. Corstens, and W. J.G. Oyen Comparison of Image-Derived and Arterial Input Functions for Estimating the Rate of Glucose Metabolism in Therapy-Monitoring 18F-FDG PET Studies J. Nucl. Med., June 1, 2006; 47(6): 945 - 949. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. J. Hoekstra, S. G. Stroobants, E. F. Smit, J. Vansteenkiste, H. van Tinteren, P. E. Postmus, R. P. Golding, B. Biesma, F. J.H.M. Schramel, N. van Zandwijk, et al. Prognostic Relevance of Response Evaluation Using [18F]-2-Fluoro-2-Deoxy-D-Glucose Positron Emission Tomography in Patients With Locally Advanced Non-Small-Cell Lung Cancer J. Clin. Oncol., November 20, 2005; 23(33): 8362 - 8370. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Lubberink, R. Boellaard, A. P. van der Weerdt, F. C. Visser, and A. A. Lammertsma Quantitative Comparison of Analytic and Iterative Reconstruction Methods in 2- and 3-Dimensional Dynamic Cardiac 18F-FDG PET J. Nucl. Med., December 1, 2004; 45(12): 2008 - 2015. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Kostakoglu and S. J. Goldsmith 18F-FDG PET Evaluation of the Response to Therapy for Lymphoma and for Breast, Lung, and Colorectal Carcinoma J. Nucl. Med., February 1, 2003; 44(2): 224 - 239. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. J. Hoekstra, O. S. Hoekstra, S. G. Stroobants, J. Vansteenkiste, J. Nuyts, E. F. Smit, M. Boers, J. W.R. Twisk, and A. A. Lammertsma Methods to Monitor Response to Chemotherapy in Non-Small Cell Lung Cancer with 18F-FDG PET J. Nucl. Med., October 1, 2002; 43(10): 1304 - 1309. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | RSS | TABLE OF CONTENTS |
| JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY | THE JOURNAL OF NUCLEAR MEDICINE |
